Myosin 9 (MYH9) Peptide
Quick Overview for Myosin 9 (MYH9) Peptide (ABIN937246)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- DAMNREVSSL KNKLRRGDLP FVVPRRMARK GAGDGSDEEV DGKADGAEAK
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MYH9 antibody,
Alternative Names: MYH9 control peptide, MYH9 antibody Blocking Peptide, Anti-MYH9 Blocking Peptide, Myosin Heavy Chain 9 Non-Muscle Blocking Peptide, DFNA17 Blocking Peptide, EPSTS Blocking Peptide, FTNS Blocking Peptide, MGC104539 Blocking Peptide, MHA Blocking Peptide, NMHC-II-A Blocking Peptide, NMMHCA Blocking Peptide, MYH9, MYH-9, MYH 9, MYH-9 Blocking Peptide, MYH 9 Blocking Peptide -
Purification
- Rabbit Anti-EGFR (Phospho-Tyr1197) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- Myosin 9 (MYH9)
-
Background
- MYH9 is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.
-
Molecular Weight
- 226 kDa
Target
-